In human non-small lung cancer cells (A549) the above compounds increase the expression of pro-apoptotic proteins from the Bcl-2, Bcl-Bax and Xs families [87], while in prostate cancer cells PC-3 increase the expression of the anti-apoptotic protein Bcl-2 [88]. Here, BCL2 is linked to prostate carcinoma.